4.15

1.22% 0.05

After Hours: 4.47 0.32 +7.71%

Artelo Biosciences Inc (ARTL)

Overview News Price History Financials Discussions Forecast Stock Split

Artelo Biosciences Inc stock is traded at $4.15, with a volume of 305.38K. It is up +1.22% in the last 24 hours and up +499.71% over the past month. Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Previous Close:

$4.10

Open:

$4.14

24h Volume:

305.38K

Relative Volume:

0.91

Market Cap:

$2.27M

Revenue:

Net Income/Loss:

$-13.47M

P/E Ratio:

-0.1066

EPS:

-38.9215

Net Cash Flow:

$-8.38M

1W Performance:

-22.28%

1M Performance:

+499.71%

6M Performance:

-47.93%

1Y Performance:

-76.51%

1-Day Range:

$3.86

$4.20

1-Week Range:

$3.45

$4.90

52-Week Range:

$0.52

$19.91

Artelo Biosciences Inc Stock (ARTL) Company Profile

Name

Artelo Biosciences Inc

Sector

Healthcare (1068)

Industry

Biotechnology (597)

Phone

858-925-7049

Address

505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA

Employee

Twitter

@ArteloBio

Next Earnings Date

2026-08-12

Latest SEC Filings

ARTL's Discussions on Twitter

Compare ARTL vs VRTX, REGN, MRNA, ARGX, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ARTL Artelo Biosciences Inc	4.15	2.97M	0	-13.47M	-8.38M	-38.92
VRTX Vertex Pharmaceuticals Inc	514.99	130.64B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.90	80.46B	14.92B	4.42B	3.79B	41.04
MRNA Moderna Inc	182.56	57.48B	2.23B	-3.19B	-1.60B	-8.1462
ARGX Argen X Se Adr	963.79	61.58B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	368.08	39.20B	5.76B	514.49M	1.10B	4.4813

Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-08-25	Upgrade	D. Boral Capital	Hold → Buy
Feb-12-21	Initiated	Ladenburg Thalmann	Buy

Artelo Biosciences Inc Stock (ARTL) Latest News

Sep 11, 2026

Artelo Biosciences reports positive ART27.13 results in neuropathic pain model - scanx.trade

Sep 11, 2026

Artelo Biosciences at H.C. Wainwright: early data, tight cash By Investing.com - Investing.com South Africa

Sep 11, 2026

Sep 08, 2026

Artelo Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference - ca.finance.yahoo.com

Sep 08, 2026

Sep 07, 2026

Artelo Biosciences data supports ART26.12 for spinal cord injury pain - scanx.trade

Sep 07, 2026

Sep 05, 2026

Artelo Biosciences Stock Price Forecast. Should You Buy ARTL? - StockInvest.us

Sep 05, 2026

Sep 03, 2026

Artelo Biosciences Inc. Warrant (ARTLW) Peer Comparison – Compare with Others - Value Research

Sep 03, 2026

Sep 02, 2026

Artelo Biosciences Inc. Warrant (ARTLW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research

Sep 02, 2026

Artelo Biosciences Inc. Warrant (ARTLW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Sep 02, 2026

Aug 31, 2026

Artelo Biosciences Inc (NASDAQ: ARTL) Share Price, ARTL Stock News, ARTL Share Price & Updates - kalkine.ca

Aug 31, 2026

Aug 28, 2026